JF
RARE icon

Jump Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jump Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.58M Sell
286,952
-217,191
-43% -$5.39M 0.08% 288
2026
Q1 		$10.6M Buy
504,143
+388,215
+335% +$8.74M 0.14% 163
2025
Q4 		$2.67M Buy
115,928
+58,460
+102% +$1.92M 0.03% 573
2025
Q3 		$1.73M Buy
57,468
+25,795
+81% +$774K 0.02% 783
2025
Q2 		$1.15M Buy
31,673
+5,158
+19% +$186K 0.01% 921
2025
Q1 		$960K Sell
26,515
-86,301
-76% -$3.59M 0.01% 842
2024
Q4 		$4.75M Buy
112,816
+87,825
+351% +$4.36M 0.1% 273
2024
Q3 		$1.39M Sell
24,991
-2,298
-8% -$117K 0.03% 658
2024
Q2 		$1.12M Buy
+27,289
New +$1.17M 0.02% 767
2023
Q4 		– Sell
-23,436
Closed -$835K – 2160
2023
Q3 		$835K Buy
23,436
+6,295
+37% +$249K 0.03% 762
2023
Q2 		$791K Buy
17,141
+2,803
+20% +$130K 0.03% 811
2023
Q1 		$575K Sell
14,338
-40,968
-74% -$1.76M 0.02% 826
2022
Q4 		$2.56M Buy
55,306
+43,508
+369% +$1.71M 0.13% 199
2022
Q3 		$489K Buy
+11,798
New +$606K 0.02% 912

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jump Financial's RARE Position: Q2 2026 in Review

Jump Financial reduced its Ultragenyx Pharmaceutical (RARE) stake by 43% in Q2 2026, selling an estimated $5.39M and leaving 286,952 shares worth $9.58M. The position accounts for 0.08% of the portfolio, ranked #288.

Jump Financial first reported a position in RARE in Q3 2022 and has held it in 14 quarters since. The position peaked at $10.6M in Q1 2026. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Jump Financial held 286,952 shares of Ultragenyx Pharmaceutical worth $9.58M as of Q2 2026.
  • Jump Financial sold 217,191 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $5.39M.
  • Ultragenyx Pharmaceutical made up 0.08% of Jump Financial's portfolio in Q2 2026, its #288 holding.
  • Jump Financial first reported a position in Ultragenyx Pharmaceutical in Q3 2022 and has held it in 14 quarters since.
  • Jump Financial's Ultragenyx Pharmaceutical position peaked at $10.6M in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.